| Objective:To observe the clinical effect of Jiejing Dingxuan Decoction combined with cervical traction on vertigo symptoms of cervical spondylosis of vertebral artery type(syndrome of upper hyperactivit y of liver yang).The vertigo visual analogue(VAS)score,cervical spondylosis of vertebral artery type functional assessment scale(FS-CSA)score and the blood flow velocity of vertebral artery and basilar artery detected by transcranial Doppler(TCD)were used as clinical observation indexes to evaluate the clinical efficacy of this therapy in improving vertigo symptoms of vertebral artery type cervical spondylosis,and to explore the mechanism of this therapy.Methods: Sixty patients with cervical spondylosis of vertebral artery type were screened from January 2018 to December 2018 at the outpatient clinic of the Bone Injury Diagnosis and Treatment Center of Henan Traditional Chinese Medicine Hospital.All the patients met the diagnostic criteria of cervical spondylosis of vertebral artery type and the dialectical criteria of syndrome of hyperactivit y of liver-yang in tradit ional Chinese medicine.According to the order of patients,they were randomly divided into observation group and control group,30 cases in each group.In the observation group,there were 12 males and 18 females,with an average age of 44.43±6.04 and an average course of 5.89±2.60 weeks.In the control group,there were 11 males and 19 females,with an average age of 46.57±5.70 years and an average course of 6.33±2.51 weeks.There was no significant difference between the two groups(P>0.05).The observation group was given oral Jiejing Dingxuan decoction,twice in the morning and evening,100 ml each time.The control group was given oral to Quan Tianma capsule,three times a day,five capsules each time.Both groups were treated with cervical traction of occipital and maxillo facial belt in sitting position for 20 minutes each time.Both groups were treated for 2weeks.By comparing the VAS score,FS-CSA score(including mental state score,functional state score and total score)and TCD to detect the blood flow velocity of vertebral artery and basilar artery before and after treatment,the differences between the two groups were compared.According to the follow-up at 3 month after the end of treatment,the cervical spondylosis of vertebral artery type funct ional assessment scale was scored again to evaluate the long-term efficacy of the two therapies.Results: 1.After 2 weeks of treatment,the VAS score of the observation group was 2.33±1.40,compared with 6.53±1.46 before treatment,P<0.05;the VAS score of the control group was 3.13±1.55,compared with 6.87±1.36 before treatment,P<0.05.At the same time,the VAS scores of the observation group and the cont rol group were compared after treatment,P<0.05.It shows that after treatment,the VAS score of vertigo in both groups has been improved,and the improvement in the observation group is better than that in the treatment group.2.The blood flow velocity o f bilateral vertebral artery and basilar artery in both groups after treatment was compared with that before treatment,both of them were P <0.05.At the same time,the blood flow velocity of bilateral vertebral artery and basilar artery in the observation group and the control group after treatment were both P<0.05.3.After 2 weeks of treatment,the mental state score,functional state score and total score of the observation group after treatment were all P<0.05 compared with those before treatment,while the mental state score,functional state score and total score of the control group after treatment were P<0.05 compared with those before treatment.At the same time,after treatment,the scores of mental state,functional state and total score of the o bservation group and the control group were all P<0.05.4.During the follow-up period,the mental state score,funct ional state score and total score of the observation group after treatment were all P>0.05,while those of the control group after treatment were P<0.05.5.After treatment,6 cases of the observation group were cured,13 cases were markedly effective,8 cases were effective and 3 cases were ineffective,the total effective rate was 90.00%.In the control group,2 cases were cured,9 cases were markedly effective,14 cases were effective and 5 cases were ineffective,the total effective rate was 83.33%.There was significant difference between the two groups of their clinical efficacy(P < 0.05).Conclusion: 1.Both Jiejing Dingxuan Decoction combined with traction therapy and Tianma capsule combined with traction therapy can reduce the vertigo VAS score and FS-CSA score of CSA patients.However,the advantages of Jiejing Dingxuan Decoction combined with traction therapy are more signif icant,and it has a stable long-term effect.2.Both Jiejing Dingxuan Decoction combined with traction therapy and Tianma capsule combined with traction therapy can improve the blood flow velocit y of vertebral artery and basilar artery in CSA patients,but the effect of the former is more obvious.3.Oral Jiejing Dingxuan Decoction combined with cervical traction can relieve contracture of muscles and blood vessels,restore mechanical balance of cervical spine,improve blood circulation,and alleviate or ev en eliminate vertigo symptoms in CSA patients.In addition,the therapy has remarkable efficiency and safet y,and has good clinical application value. |
PDF Full Text Request